SCHEMBL5494620

SCHEMBL5494620

NCCCCC(N)NC(=O)CCCN

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.45
SLC6A5 Q9Y345 1/20 0.42
FOLH1 Q04609 1/20 0.42
NMT1 P30419 4/20 0.40
NMT2 O60551 3/20 0.40
RNPEP Q9H4A4 1/20 0.39
LMNA P02545 2/20 0.38
THRB P10828 2/20 0.38
BLM P54132 2/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
GABRR3 A8MPY1 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
HDAC3 O15379 1/20 0.38
GABBR2 O75899 1/20 0.38
CYP1A2 P05177 1/20 0.38
GABRA1 P14867 1/20 0.38
TSHR P16473 1/20 0.38
GABRB1 P18505 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11405576 0.94 SLC6A5 (0.48) GSRSLC6A5FOLH1NMT1NMT2
SCHEMBL8013202 0.88 LMNA (0.57) GSRSLC6A5FOLH1NMT1NMT2
SCHEMBL7215943 0.86 SLC6A5 (0.59) SLC6A5KMT2ADNM1GNAI3GNAO1
SCHEMBL7209829 0.86 SLC6A5 (0.59) SLC6A5KMT2ADNM1GNAI3GNAO1
SCHEMBL7215978 0.86 SLC6A5 (0.59) SLC6A5KMT2ADNM1GNAI3GNAO1
SCHEMBL2363939 0.85 CYP2D6 (0.55) GSRSLC6A5FOLH1NMT1NMT2
SCHEMBL5494287 0.78 GSR (0.34) GSRSLC6A5FOLH1NMT1NMT2
SCHEMBL9442358 0.78 GSR (0.47) GSRSLC6A5FOLH1RNPEPLMNA
SCHEMBL2679022 0.78 GSR (0.52) GSRSLC6A5FOLH1RNPEPLMNA
SCHEMBL232587 0.77 SLC6A5 (0.65) GSRSLC6A5FOLH1NMT1NMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1159292-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY Administrators of The Tulane Educational Fund (US) 2001-12-05 EP claimed
WO-2000009537-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2000-02-24 WO claimed
US-7250399-B2 Compounds having growth hormone releasing activity THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2007-07-31 US disclosed
US-6468974-B1 OLIGOPEPTIDES THAT PROVIDE DESIRABLE IN VITRO AND IN VIVO GROWTH HORMONE RELEASING ACTIVITY AND HAVE AT LEAST ONE OTHER DESIRABLE BIOLOGICAL ACTIVITY SUCH AS INCREASED RETENTION TIME THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND 2002-10-22 US disclosed
US-20020151501-A1 Compounds having growth hormone releasing activity BOWERS CYRIL Y (US) 2002-10-17 US disclosed
EP-1159292-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY Administrators of The Tulane Educational Fund (US) 2001-12-05 EP disclosed
WO-2000009537-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151501-A1 Compounds having growth hormone releasing activity GHSR, GHRHR, NPY1R GSR 3429/4885SLC6A5 4169/4885FOLH1 3078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.